Nelson Sun - 09 Feb 2026 Form 4 Insider Report for Aardvark Therapeutics, Inc. (AARD)

Role: Chief Financial Officer
Signature: /s/ Nelson Sun
Issuer symbol: AARD
Transactions as of: 09 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 11 Feb 2026, 21:00:21 UTC
Previous filing: 12 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Sun Nelson	Chief Financial Officer	C/O AARDVARK THERAPEUTICS, INC., 4370 LA JOLLA VILLAGE DRIVE, SUITE 1050, SAN DIEGO	/s/ Nelson Sun	11 Feb 2026	0002045377

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AARD	Stock option (right to buy)	Award	$0	-70,549	-50%	$0.000000	70,549	09 Feb 2026	Common Stock	70,549	$13.48	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/4th of the shares subject to the option shall vest on February 9, 2027, and 1/48th of the shares subject to the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.